
Sign up to save your podcasts
Or
A new study finds that Medicare Advantage plans were overpaid by billions of dollars each year from 2017 to 2020. The cost of employer-sponsored health insurance is expected to surge next year. And, researchers are investigating whether weight loss drugs Ozempic and Wegovy could be used to treat alcohol addiction and dementia. That’s coming up on today’s episode of Gist Healthcare Daily.
Hosted on Acast. See acast.com/privacy for more information.
4.8
134134 ratings
A new study finds that Medicare Advantage plans were overpaid by billions of dollars each year from 2017 to 2020. The cost of employer-sponsored health insurance is expected to surge next year. And, researchers are investigating whether weight loss drugs Ozempic and Wegovy could be used to treat alcohol addiction and dementia. That’s coming up on today’s episode of Gist Healthcare Daily.
Hosted on Acast. See acast.com/privacy for more information.
1,275 Listeners
874 Listeners
1,754 Listeners
8,595 Listeners
1,358 Listeners
637 Listeners
111,512 Listeners
56,071 Listeners
1,437 Listeners
468 Listeners
1,078 Listeners
177 Listeners
391 Listeners
5,952 Listeners
141 Listeners